Showing results (1-10 of 317) with videos related to
Sort By:
Pageof 32
Biological Psychiatry|January 23, 1999
Pharmacologic strategies for augmenting cognitive performance in schizophreniaJ I Friedman, H Temporini, K L DavisBiological Psychiatry|November 24, 1999
The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's diseaseJ I Friedman, D N Adler, K L DavisBiological Psychiatry|October 6, 1999
Cognitive and functional changes with aging in schizophreniaJ I Friedman, P D Harvey, E Kemether, et al.Biological Psychiatry|June 6, 2000
Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia: less impairment in reading compared with other skill areasP D Harvey, P J Moriarty, J I Friedman, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 28, 2001
Guanfacine treatment of cognitive impairment in schizophreniaJ I Friedman, D N Adler, H D Temporini, et al.The American Journal of Psychiatry|September 5, 2001
Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal agingJ I Friedman, P D Harvey, T Coleman, et al.Geriatrics|February 20, 1999
Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. LuddingtonK L DavisAlzheimer Disease and Associated Disorders|January 1, 1996
Issues in accelerating the pace of development for neuroprotective agentsK L DavisNeurobiology of Aging|September 1, 1989
Toward a therapeutic strategy based on amyloid precursor protein: unanswered questionsK L DavisThe Journal of Clinical Psychiatry|September 10, 1998
Future therapeutic approaches to Alzheimer's diseaseK L DavisPageof 32